Clinica's Medtech Ventures - Issue 14: CoreValve's ReValving technology holds promise for risky heart valve patients
This article was originally published in Clinica
Executive Summary
Company: CoreValve Specialty area(s): Percutaneous aortic valve replacement (PAVR) and transapical aortic valve replacement (TAVR) Based in: Irvine, California, US Founded in: 2001 No. of employees: 50 Total investment received to date: $65m from Maverick Capital, Sofinnova Partners, Apax Partners and HealthCap